Ortie Capital InvestmentS.A.

Activities of head offices

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-04-30
Share capital
10 000 000,00 PLN
Activity description

Ortie Capital Investment is a private equity and venture capital fund that invests in early-stage companies across various sectors, including medical services, medical equipment production, healthcare, pharmaceuticals, sports and recreation, logistics, and financial services. The fund provides both financial and managerial support, with investments ranging from 300,000 to 3 million PLN and an average investment duration of up to three years. Current investments include NETTLE S.A., which offers healthcare services and dedicated distribution processes for pharmaceuticals to hospitals and pharmacies.

Registered address
Hubska 44, 50-502 Wrocław, Poland
Website
ortie.plWebsite active
Email
Email address current
Phone

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 7.77mMedianUSD 130.35kAverageUSD 54.57m
Net profit
This companyUSD 6.30mMedianUSD 1.04kAverageUSD -278.42k
Operating costs
This companyUSD 908.52kMedianUSD 51.90kAverageUSD 52.39m
Assets
This companyUSD 95.29mMedianUSD 539.69kAverageUSD 95.69m

Bank accounts

Registered as a VAT taxpayer on 2004-09-24. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

6 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
Dec 7, 2020Commercial Companies Code notice
Nov 20, 2020Commercial Companies Code notice
Nov 5, 2020Commercial Companies Code notice
Oct 21, 2020Commercial Companies Code notice
Sep 23, 2020Commercial Companies Code notice

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,211
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,182
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,095

Tenders

No recorded participation in tenders.

Authorized Representatives

Paweł Andrzej Szewczyk – President of the Management Board
Barbara Wojtas – Attorney-in-fact (joint)
Piotr Król – Vice President of the Management Board

Manner of representation

For representing the company in external relations, that is, for making declarations of will on its behalf and signing documents producing legal effects, the following are authorised: 1) in the case of a one-person management board, the sole member of the management board, independently; 2) in the case of a multi-member management board, two members of the management board jointly, or one member of the management board jointly with a commercial proxy.

Supervisory board

Krzysztof Bernard Wojtas – Supervisory Board Member
Wiesław Lech Bociek – Supervisory Board Member
Marcin Dworniczak – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
ERG Medicalsp. z o.o.
19.8969%
Nesselsp. z o.o.
–

Competitors

Name
Adamed Technologysp. z o.o.
Enterprise Investorssp. z o.o.
Radix Advisorssp. z o.o.
InvestcareS.A.
JET Investment Polandsp. z o.o.

Change history

DateEvent
2018-11-20PKD change
2018-02-02Share capital change
2017-10-24Share capital change
2008-05-29PKD change
2007-09-26Share capital change

FAQ

Last updated: 2026-07-09